Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHSE: 688488)
Health Care · Biotechnology · CN
CN¥16.49
-9.15% today · -9.4% 1Y
Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHSE: 688488) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.03B and employs 735 people.
Over the last twelve months the share price has lost 9.4%, trading between 11.40 and 22.55.
Tweenvest scores Jiangsu Aidea Pharmaceutical Group Co., Ltd. across four factors: quality 59/100, value 63/100, growth 87/100. Its strongest factor is growth.
688488 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.03B
- Revenue (TTM)
- $101.39M
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 0.46
- 52-week high
- CN¥22.55
- 52-week low
- CN¥11.40
- Avg volume (3M)
- —
- Shares outstanding
- 420.78M
- Employees
- 735
- Next earnings
- —
About Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Jiangsu Aidea Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and commercialization of diverse pharmaceutical products. Its extensive offerings encompass a range of medications including folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules. The company also provides pharmaceutical raw materials. Established in 2009, Jiangsu Aidea Pharmaceutical is headquartered in Yangzhou, China.
- ISIN
- CNE1000041S6
- Founded
- 2009
- Listed since
- Jul 20, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.